---
title: "China Resources Pharmaceutical Invests in Health Consumer Products Industrial Park"
description: "China Resources Pharmaceutical Group Ltd. announced an investment of approximately RMB 1.421 billion by its subsidiary, Dong-E-E-Jiao Company Limited, to construct a Health Consumer Products Industria"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/275438455.md"
published_at: "2026-02-10T10:07:00.000Z"
---

# China Resources Pharmaceutical Invests in Health Consumer Products Industrial Park

> China Resources Pharmaceutical Group Ltd. announced an investment of approximately RMB 1.421 billion by its subsidiary, Dong-E-E-Jiao Company Limited, to construct a Health Consumer Products Industrial Park. The project will encompass manufacturing, warehousing, and logistics facilities, funded by internal resources. This investment aims to enhance the company's health consumer products business and support its strategic growth model.

China Resources Pharmaceutical Group Ltd. announced that its non-wholly-owned subsidiary, Dong-E-E-Jiao Company Limited, will invest approximately RMB 1.421 billion in the construction of a Health Consumer Products Industrial Park. The project will include manufacturing, warehousing, and logistics facilities and will be funded by Dong-E-E-Jiao’s internal resources. This investment aims to expand the company’s health consumer products business and support the implementation of Dong-E-E-Jiao’s strategic growth model. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260210-12020709), on February 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [000423.CN - DEEJ](https://longbridge.com/en/quote/000423.CN.md)
- [03320.HK - CHINARES PHARMA](https://longbridge.com/en/quote/03320.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 2026 Outlook: What to Watch for From WELL | IWBI outlines its 2026 outlook, emphasizing the launch of One WELL, the next generation of the WELL Standard, aimed at a | [Link](https://longbridge.com/en/news/276136645.md) |
| 20:30 ETPhilanthropic Partnership Backs Country-Led Research to Guide the Use of AI in Health | The Gates Foundation, Novo Nordisk Foundation, and Wellcome have announced a joint investment of $60 million to support  | [Link](https://longbridge.com/en/news/276399782.md) |
| ZAWYA-PRESSR: Unilever and Google Cloud partner to pioneer next generation of consumer goods technologies | Unilever and Google Cloud have announced a five-year partnership aimed at transforming Unilever's business through advan | [Link](https://longbridge.com/en/news/276228906.md) |
| 14:13 ETMediKarma Validates "Agentic AI" in Clinical Intervention Study: Demonstrates 50% A1C Reduction; Proves Friction-Free Alternative to ChatGPT | MediKarma announced successful results from a 120-day clinical intervention study with Dallas Endocrinology, validating  | [Link](https://longbridge.com/en/news/276159549.md) |
| 09:15 ETAspen Publishing and Rhetoric Partner to Transform Legal Education Through AI-Powered Experiential Learning | Aspen Publishing and Rhetoric have partnered to enhance legal education by integrating AI-driven skills training into th | [Link](https://longbridge.com/en/news/276343563.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.